Regeneron funds independent medical education and research conferences to advance scientific and medical knowledge through professional development and educational initiatives.
Regeneron Pharmaceuticals' Third-party Research Requests Program funds independent, investigator-initiated scientific research projects that prioritize scientific rigor and regulatory compliance.
Medical and Scientific Research supports university researchers through facilities, research resources, and laboratory programs that pursue innovative science to advance knowledge and improve human health.
Innovation in Regulatory Science supports academic researchers developing tools, standards, and approaches to improve health product evaluation and strengthen regulatory decisions that protect the public.
Medical Research Support backs third-party investigators studying Illumina products and technology in four clinical areas to advance genomics research and its use in areas of clinical need.